Market: median 1d +0.0% · breadth 38.3% advancing across 188 names
Data as of — announcements 2026-07-24 · flow 2026-07-21 · prices 2026-07-23
New today: ATV, BRN, CTO, EVR, OM1, REE. Continuing: VMM.New names versus yesterday's letter, so a continuing story doesn't read as fresh news.
Read these (6)
Today's announcements worth minutes, not seconds — triaged by deterministic rules (a raise, a result into live flow, quantified materiality). The LLM annotates; it never picks the bucket.
ATV has raised $3.6M at a significant 30% discount to 15-day VWAP, backed by high-calibre institutional investors (Antipodes, MWP, Scobie Ward), validating management's pivot and network automation strategy in the AI/telecom infrastructure wave. The substantial oversubscription and quality investor syndicate suggest strong confidence in the turnaround narrative, with capital directed toward product development, sales growth, and working capital.
💰Placement size: $3.6M · Issue price: $0.015/share · Shares issued: 242.3M · Discount to last close: 16.7%
Materiality: Raise equals ~19% of $19M market cap; material recapitalisation to support growth acceleration at a strategic inflection point.
Priced in? Stock down 22% over 20d pre-announcement with no 5d movement; significant discount pricing suggests limited anticipation—new institutional backing and executive validation likely a catalyst.
BRN · $291M — Expiration of LDA Put Option Agreement
BrainChip's LDA Put Option facility has expired cleanly; the A$1M failure fee was satisfied through collateral share sales without tapping company cash, and ~6M remaining shares will be liquidated orderly by LDA over coming weeks with net proceeds returned to BRN. This marks a clean deleveraging event that preserves cash and removes a legacy financing overhang.
Materiality: Collateral liquidation (~12.96M shares total) represents ~0.3% dilution per share; A$1M failure fee avoided cash drain on a A$303M market cap company; net proceeds expected to offset fees.
Priced in? Stock down 7% over 5d and 16% over 20d before announcement; decline likely reflects broader tech weakness rather than this orderly resolution, which removes uncertainty.
CTO faces acute debt distress: a five-year secured loan was abruptly assigned to a new lender and a default notice issued within 48 hours, followed by a forbearance deed that has already been alleged breached. The company is seeking refinancing to repay the facility but has only in-principle (non-binding) support, creating material solvency risk.
💰Secured loan facility: 5 years outstanding, assigned to DEP Nominees 3 June 2026 · Default notice: 5 June 2026, two days after assignment · Forbearance Deed: Executed 3 July 2026, lender reserves enforcement rights · Further default alleged: 16 July 2026
Materiality: Loan assignment and default notice represent fundamental refinancing risk to a $33m market-cap junior; forbearance breakdowns and alleged further defaults within 13 days suggest lender-company relations are deteriorating rapidly.
Priced in? Stock down 13% over 20d and 9% over 5d; timing of this update (24 July) follows forbearance execution (3 July) and alleged further default (16 July), suggesting negative momentum was already underway but full scope of lender aggression now disclosed.
EVR has secured $1m underwriting with director and major shareholder support via sub-underwriting of the full amount, de-risking a $1.52m rights issue to fund antimony processing plant advancement in Mexico. The insider commitment indicators confidence in the Tecomatlán ramp-up strategy despite the small $15m market cap.
Materiality: Rights issue (~$1.5m) represents ~10% of market cap; underwriting backstop (~$1m) covers 66% of target, materially reducing dilution risk and execution uncertainty.
Priced in? Stock down 17% over 20 days pre-announcement with no 5-day run-up; insider sub-underwriting is new information and likely supported recent volatile broker flows (2.5× volume spike).
OM1 · $6M — Maiden Sampling Defines REE-Nb and Antimony Targets, Montana
Maiden geochemical sampling at Radix confirms REE-Nb potential with coherent multi-catchment anomalies (146.50 ppm Nd+Pr, 560.43 ppm TREE+Y) and a notable discrete 209 ppm Nb rock result, validating Phase 1 desktop targeting. Early-stage reconnaissance data prioritizes follow-up mapping and mineralogical characterization; results do not yet demonstrate resource-scale continuity or grades.
Materiality: Early-stage exploration data on a $6m market-cap junior; reconnaissance-scale findings support thesis but carry no mineral resource implication; tenure reduction at Stibnite Ridge (third-party claims) indicators management focus on higher-potential ground.
Priced in? Stock flat over 5d into announcement; down 25% over 20d (prior weakness unrelated to this specific news); maiden sampling results appear to be new Company-generated data with no obvious pre-run.
REE — RareX-Iluka Consortium advance to final stages of Mrima Hill
RareX–Iluka Consortium has progressed from Expression of Interest to RFP stage in Kenya's Mrima Hill tender, anchored by Iluka's government-backed Eneabba refinery and a binding offtake term sheet—removing downstream technical and construction risk. The proposal combines Kenya mine development with integrated refining in Australia and secured US/allied supply chain commitments, positioning the consortium for competitive advantage in the final tender phase.
💰Project stage: Request for Proposal (RFP) shortlist · Offtake partner: Iluka Resources (binding term sheet) · Downstream refinery: Eneabba (commissioning 2027, A$1.65bn Australian Government-backed) · Market cap: A$13m
Materiality: Stage advancement in a material project; downstream refinery backing (A$1.65bn) significantly de-risks execution; insufficient data on deal value or REE reserve tonnage to quantify against A$13m market cap
Priced in? Stock down 15% over 5 days into announcement; no positive run-up; news may represent a genuine catalyst but sentiment already reflected
Who bought and sold, by broker cohort, on a T+3 lag — spikes vs each stock's own baseline, multi-session streaks, and warnings where 'buying' is likely someone absorbing an exit.